NCT03013023

Brief Summary

This randomized controlled trial will use a longitudinal repeated-measures design to examine the effects of two interventions, behavioral support interventions and a parent-infant transactional program, on parents' stress, PPD and sleep quality, parent-infant interactions, and their preterm infants' stress (saliva cortisol levels), sleep patterns, emotional regulation, and neurobehavioral developmental outcomes from 7 days to 2 years corrected age.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2015

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

December 29, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 6, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

November 3, 2020

Status Verified

October 1, 2020

Enrollment Period

1.9 years

First QC Date

December 29, 2016

Last Update Submit

October 31, 2020

Conditions

Keywords

Behavioral and Transaction InterventionsParents' Biopsychosocial Well-beingPreterm InfantsSleepSalivary cortisol

Outcome Measures

Primary Outcomes (4)

  • Parent stress

    Accessed by Parenting Stress Index-Short form (PSI-SF)

    7days to 12 months

  • Parent depression

    Accessed by the Edinburgh Postnatal Depression Scale (EPDS)

    7days to 12 months

  • Parent sleep

    Accessed by Pittsburgh Sleep Quality Index

    7days to 12 months

  • Parent social support

    Accessed by the Social Support Rating Scale (SSRS)

    7days to 12 months

Secondary Outcomes (3)

  • Parent-infant interaction

    1 month to 6 months

  • Preterm infant's sleep

    up to 3 months

  • Preterm infant's stress

    up to 3 months

Study Arms (4)

Routine care

PLACEBO COMPARATOR

Control group

Behavioral: Routine care

Behavioral-support interventions (BS)

ACTIVE COMPARATOR

NNS, FT, positional support, and oral sucrose feeding will be provided while infants are undergoing painful procedures

Behavioral: BS

Parent-infant transaction program (PITP)

ACTIVE COMPARATOR

The PITP will be a six-session, one-on-one teaching intervention beginning on day 22 after birth, with four sessions at bedside, and two home-visit sessions within the first month after discharge.

Behavioral: PITP

BS+PITP

ACTIVE COMPARATOR

Behavioral-support interventions + Parent-infant transaction program

Behavioral: BS+PITP

Interventions

BSBEHAVIORAL

NNS, FT, positional support, and oral sucrose feeding

Behavioral-support interventions (BS)
Routine careBEHAVIORAL

Routine NICU care

Routine care
PITPBEHAVIORAL

Parents will learn to regulate infant responses while implementing caregiving activities.

Parent-infant transaction program (PITP)
BS+PITPBEHAVIORAL

Parents will learn to regulate infant responses while implementing caregiving activities. Supportive interventions, i.e., NNS, FT, positional support, and oral sucrose feeding, will be provided while infants are undergoing painful procedures.

BS+PITP

Eligibility Criteria

Age28 Weeks - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Gestational age (GA) \> 28 weeks and \< 37 weeks
  • Postbirth age \>2 days
  • Stable condition (score\<20 on the Neonatal Therapeutic Intervention Scoring System \[NTISS\] for disease severity).
  • Parents are not diagnosed with mental illness or some other illness known to influence/confound the outcome variables
  • Parents are fluent in Chinese
  • Parents do not use drugs
  • Parents agree to participate in this study

You may not qualify if:

  • Congenital anomalies
  • Neurologic impairment including convulsion, intraventricular hemorrhage \> grade II or periventricular leukomalacia
  • Documented congenital or nosocomial (infection acquired at hospital after birth) sepsis
  • Surgery
  • Severe medical conditions requiring treatments such as cortisol supplementation, sedatives, muscle relaxants, antiepileptic, or analgesic drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Behavior

Study Officials

  • Jen-Jiuan Liaw, Professor

    Professor, School of Nursing, National Defense Medical Center, Taipei, Taiwan, ROC.

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator, National Defense Medical Center, Taiwan

Study Record Dates

First Submitted

December 29, 2016

First Posted

January 6, 2017

Study Start

April 1, 2015

Primary Completion

March 1, 2017

Study Completion

August 1, 2017

Last Updated

November 3, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share